(Q70413001)
Statements
Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide (English)
E M Airaksinen
K Koivisto
T Keränen
A Pitkänen
P J Riekkinen
S S Oja
K M Marnela
J V Partanen
O Tokola
1 September 1987